RIPK3 activation induces TRIM28 derepression in cancer cells and enhances the anti-tumor microenvironment.
Han-Hee ParkHwa-Ryeon KimSang-Yeong ParkSung-Min HwangSun Mi HongSangwook ParkHo Chul KangMichael J MorganJong-Ho ChaDakeun LeeJae-Seok RoeYou-Sun KimPublished in: Molecular cancer (2021)
Our data suggest that RIPK3 activation-dependent derepression of TRIM28 in cancer cells leads to increased immunostimulatory cytokine production in the tumor microenvironment, which then contributes to robust cytotoxic anti-tumor immunity.